These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1820912)

  • 1. A method to optimize the design parameters of sustained release preparations.
    Cadorniga R; Frutos G; Martin PJ
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():385-8. PubMed ID: 1820912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology.
    Shah SN; Asghar S; Choudhry MA; Akash MS; ur Rehman N; Baksh S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1470-8. PubMed ID: 19929206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general code to predict the drug release kinetics from different shaped matrices.
    Barba AA; d'Amore M; Chirico S; Lamberti G; Titomanlio G
    Eur J Pharm Sci; 2009 Feb; 36(2-3):359-68. PubMed ID: 19022380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogels in controlled release formulations: network design and mathematical modeling.
    Lin CC; Metters AT
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1379-408. PubMed ID: 17081649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical models for the release of drugs from matrix tablets.
    Cobby J
    J Biomed Mater Res; 1978 Sep; 12(5):627-34. PubMed ID: 701299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.
    Chow MS; Sun H
    Pharmacotherapy; 1990; 10(6):400-5. PubMed ID: 2287561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation strategies for absorption windows.
    Davis SS
    Drug Discov Today; 2005 Feb; 10(4):249-57. PubMed ID: 15708743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modeling of drug delivery.
    Siepmann J; Siepmann F
    Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic modeling on drug release from controlled drug delivery systems.
    Dash S; Murthy PN; Nath L; Chowdhury P
    Acta Pol Pharm; 2010; 67(3):217-23. PubMed ID: 20524422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egg shell membrane as a substrate for optimizing in vitro transbuccal delivery of glipizide.
    Philip AK; Singh N; Pathak K
    Pharm Dev Technol; 2009; 14(5):540-7. PubMed ID: 19552562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic quantitation of naltrexone release from several sustained-release delivery systems.
    Reuning RH; Liao SH; Staubus AE
    NIDA Res Monogr; 1981; 28():172-84. PubMed ID: 6791003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of dispersed-drug delivery from planar polymeric systems: optimizing analytical solutions.
    Helbling IM; Ibarra JC; Luna JA; Cabrera MI; Grau RJ
    Int J Pharm; 2010 Nov; 400(1-2):131-7. PubMed ID: 20816929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
    Koch HP
    Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of nano drug carriers towards optimum release rate.
    Ng EY; Ng WK
    J Med Eng Technol; 2007; 31(4):243-52. PubMed ID: 17566928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of experimental design methodology in development and optimization of drug release method.
    Kincl M; Turk S; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):39-49. PubMed ID: 15707730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of gastric floating sustained-release capsules of Tripterygium wilfordii by using multiparticulate time-controlled release technology].
    Zhang W; Song H; Zhang Q
    Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(22):2867-71. PubMed ID: 20209947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.